Potential treatments for Alzheimer’s disease, cancer and many other illnesses are being blocked by anti-drug laws, according to a new editorial review published in Nature Reviews Neuroscience. Lead author David Nutt, chair of neuropsychopharmacology at Imperial College London, and his colleagues argue that tight restrictions on research on illegal drugs like marijuana and “legal highs” are hindering progress in neuroscience ...